Epigenetic control of aging

Antioxidants and Redox Signaling

Volumn 14, Issue 2, 2011, Pages 241-259

  Muñoz Najar, Ursula ^a   Sedivy, John M ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE;

AGING; DNA METHYLATION; EPIGENETICS; HUMAN; MUTATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN MODIFICATION; REVIEW;

AGING; ANIMALS; CELL AGING; EPIGENESIS, GENETIC; HUMANS; MODELS, BIOLOGICAL; PHENOTYPE;

EID: 78650273646     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2010.3250     Document Type: Review

References (246)

1. Adams PD. Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and aging. Gene 397: 84-93, 2007.
2. Ahmad K and Henikoff S. Histone H3 variants specify modes of chromatin assembly. Proc Natl Acad Sci USA 99 Suppl 4: 16477-16484, 2002.
3. Ahmad K and Henikoff S. The histone variant H3.3 marks active chromatin by replication-independent nucleosome assembly. Mol Cell 9: 1191-1200, 2002.
4. Aubert G and Lansdorp PM. Telomeres and aging. Physiol Rev 88: 557-579, 2008.
5. Bahar R, Hartmann CH, Rodriguez KA, Denny AD, Bu-suttil RA, Dolle ME, Calder RB, Chisholm GB, Pollock BH, Klein CA, and Vijg J. Increased cell-tocell variation in gene expression in ageing mouse heart. Nature 441: 1011-1014, 2006.
6. Bandyopadhyay D and Medrano EE. The emerging role of epigenetics in cellular and organismal aging. Exp Gerontol 38: 1299-1307, 2003.
7. Bannister AJ, Schneider R, and Kouzarides T. Histone methylation: dynamic or static? Cell 109: 801-806, 2002.
8. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ra-maswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, and Sinclair DA. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444: 337-342, 2006.
9. Baur JA, Zou Y, Shay JW, and Wright WE. Telomere position effect in human cells. Science 292: 2075-2077, 2001.
10. Bedford MT. Arginine methylation at a glance. J Cell Sci 120: 4243-4246, 2007.
11. Benetti R, Garcia-Cao M, and Blasco MA. Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres. Nat Genet 39: 243-250, 2007.
12. Ben-Porath I and Weinberg RA. When cells get stressed: an integrative view of cellular senescence. J Clin Invest 113: 8-13, 2004.
13. Ben-Porath I and Weinberg RA. The signals and pathways activating cellular senescence. Int J Biochem Cell Biol 37: 961-976, 2005.
14. Berger SL. The complex language of chromatin regulation during transcription. Nature 447: 407-412, 2007.
15. Bernard D, Martinez-Leal JF, Rizzo S, Martinez D, Hudson D, Visakorpi T, Peters G, Carnero A, Beach D, and Gil J. CBX7 controls the growth of normal and tumorderived prostate cells by repressing the Ink4a=Arf locus. Oncogene 24: 5543-5551. Write to the Help Desk NCBI | NLM | NIH Department of Health & Human Services Privacy Statement | Freedom of Information Act | Disclaimer Aug 7 2006 07:06:54, 2005.
16. Bernstein BE, Meissner A, and Lander ES. The mammalian epigenome. Cell 128: 669-681, 2007.
17. Bernstein E and Allis CD. RNA meets chromatin. Genes Dev 19: 1635-1655, 2005.
18. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 16: 6-21, 2002.
19. Bird A. Perceptions of epigenetics. Nature 447: 396-398, 2007.
20. Birney E, Stamatoyannopoulos JA, Dutta A, Guigo R, Gingeras TR, Margulies EH, Weng Z, Snyder M, Dermit-zakis ET, Thurman RE, Kuehn MS, Taylor CM, Neph S, Koch CM, Asthana S, Malhotra A, Adzhubei I, Greenbaum JA, Andrews RM, Flicek P, Boyle PJ, Cao H, Carter NP, Clelland GK, Davis S, Day N, Dhami P, Dillon SC, Dorschner MO, Fiegler H, Giresi PG, Goldy J, Hawrylycz M, Haydock A, Humbert R, James KD, Johnson BE, Johnson EM, Frum TT, Rosenzweig ER, Karnani N, Lee K, Le-febvre GC, Navas PA, Neri F, Parker SC, Sabo PJ, Sandstrom R, Shafer A, Vetrie D, Weaver M, Wilcox S, Yu M, Collins FS, Dekker J, Lieb JD, Tullius TD, Crawford GE, Sunyaev S, Noble WS, Dunham I, Denoeud F, Reymond A, Kapranov P, Rozowsky J, Zheng D, Castelo R, Frankish A, Harrow J, Ghosh S, Sandelin A, Hofacker IL, Baertsch R, Keefe D, Dike S, Cheng J, Hirsch HA, Sekinger EA, Lagarde J, Abril JF, Shahab A, Flamm C, Fried C, Hackermuller J, Hertel J, Lindemeyer M, Missal K, Tanzer A, Washietl S, Korbel J, Emanuelsson O, Pedersen JS, Holroyd N, Taylor R, Swarbreck D, Matthews N, Dickson MC, Thomas DJ, Weirauch MT, Gilbert J, Drenkow J, Bell I, Zhao X, Srini-vasan KG, Sung WK, Ooi HS, Chiu KP, Foissac S, Alioto T, Brent M, Pachter L, Tress ML, Valencia A, Choo SW, Choo CY, Ucla C, Manzano C, Wyss C, Cheung E, Clark TG, Brown JB, Ganesh M, Patel S, Tammana H, Chrast J, Henrichsen CN, Kai C, Kawai J, Nagalakshmi U, Wu J, Lian Z, Lian J, Newburger P, Zhang X, Bickel P, Mattick JS, Carninci P, Hayashizaki Y, Weissman S, Hubbard T, Myers RM, Rogers J, Stadler PF, Lowe TM, Wei CL, Ruan Y, Struhl K, Gerstein M, Antonarakis SE, Fu Y, Green ED, Karaoz U, Siepel A, Taylor J, Liefer LA, Wetterstrand KA, Good PJ, Feingold EA, Guyer MS, Cooper GM, Asimenos G, Dewey CN, Hou M, Nikolaev S, Montoyaburgos JI, Loytynoja A, Whelan S, Pardi F, Massingham T, Huang H, Zhang NR, Holmes I, Mullikin JC, Ureta-Vidal A, Paten B, Seringhaus M, Church D, Rosenbloom K, Kent WJ, Stone EA, Batzoglou S, Goldman N, Hardison RC, Haussler D, Miller W, Sidow A, Trinklein ND, Zhang ZD, Barrera L, Stuart R, King DC, Ameur A, Enroth S, Bieda MC, Kim J, Bhinge AA, Jiang N, Liu J, Yao F, Vega VB, Lee CW, Ng P, Shahab A, Yang A, Moqtaderi Z, Zhu Z, Xu X, Squazzo S, Oberley MJ, Inman D, Singer MA, Richmond TA, Munn KJ, Rada-Iglesias A, Wallerman O, Komorowski J, Fowler JC, Couttet P, Bruce AW, Dovey OM, Ellis PD, Langford CF, Nix DA, Euskirchen G, Hartman S, Urban AE, Kraus P, Van Calcar S, Heintzman N, Kim TH, Wang K, Qu C, Hon G, Luna R, Glass CK, Rosenfeld MG, Aldred SF, Cooper SJ, Halees A, Lin JM, Shulha HP, Zhang X, Xu M, Haidar JN, Yu Y, Ruan Y, Iyer VR, Green RD, Wadelius C, Farnham PJ, Ren B, Harte RA, Hinrichs AS, Trumbower H, Clawson H, Hillman-Jackson J, Zweig AS, Smith K, Thakkapallayil A, Barber G, Kuhn RM, Karolchik D, Armengol L, Bird CP, de Bakker PI, Kern AD, Lopez-Bigas N, Martin JD, Stranger BE, Woodroffe A, Davydov E, Dimas A, Eyras E, Hall-grimsdottir IB, Huppert J, Zody MC, Abecasis GR, Estivill X, Bouffard GG, Guan X, Hansen NF, Idol JR, Maduro VV, Maskeri B, McDowell JC, Park M, Thomas PJ, Young AC, Blakesley RW, Muzny DM, Sodergren E, Wheeler DA, Worley KC, Jiang H, Weinstock GM, Gibbs RA, Graves T, Fulton R, Mardis ER, Wilson RK, Clamp M, Cuff J, Gnerre S, Jaffe DB, Chang JL, Lindblad-Toh K, Lander ES, Kor-iabine M, Nefedov M, Osoegawa K, Yoshinaga Y, Zhu B, and de Jong PJ. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447: 799-816, 2007.
21. Blasco MA. The epigenetic regulation of mammalian telo-meres. Nat Rev Genet 8: 299-309, 2007.
22. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, and Wright WE. Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349-352, 1998.
23. Boehm M and Slack F. A developmental timing microRNA and its target regulate life span in C. elegans. Science 310: 1954-1957, 2005.
24. Bordone L and Guarente L. Calorie restriction, SIRT1 and metabolism: understanding longevity. Nat Rev Mol Cell Biol 6: 298-305, 2005. (Pubitemid 40516896)
25. Bornman DM, Mathew S, Alsruhe J, Herman JG, and Gabrielson E. Methylation of the E-cadherin gene in bladder neoplasia and in normal urothelial epithelium from elderly individuals. Am J Pathol 159: 831-835, 2001.
26. Bracken AP, Kleine-Kohlbrecher D, Dietrich N, Pasini D, Gargiulo G, Beekman C, Theilgaard-Monch K, Minucci S, Porse BT, Marine JC, Hansen KH, and Helin K. The Poly-comb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev 21: 525-530, 2007.
27. Brookes S, Rowe J, Ruas M, Llanos S, Clark PA, Lomax M, James MC, Vatcheva R, Bates S, Vousden KH, Parry D, Gruis N, Smit N, Bergman W, and Peters G. INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescence. EMBO J. 21: 2936-2945.
28. Write to the Help Desk NCBI | NLM | NIH Department of Health & Human Services Privacy Statement | Freedom of Information Act | Disclaimer Aug 7 2006 07:06:54, 2002.
29. Brown DR, Wong BS, Hafiz F, Clive C, Haswell SJ, and Jones IM. Normal prion protein has an activity like that of superoxide dismutase. Biochem J 344 Pt 1: 1-5, 1999.
30. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, Hu LS, Cheng HL, Jedrychowski MP, Gygi SP, Sinclair DA, Alt FW, and Greenberg ME. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303: 2011-2015, 2004.
31. Calestagne-Morelli A and Ausio J. Long-range histone acetylation: biological significance, structural implications, and mechanisms. Biochem Cell Biol 84: 518-527, 2006.
32. Campisi J and d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8: 729-740, 2007.
33. Casillas MA, Jr., Lopatina N, Andrews LG, and Tollefsbol TO. Transcriptional control of the DNA methyltransferases is altered in aging and neoplastically-transformed human fibroblasts. Mol Cell Biochem 252: 33-43, 2003.
34. Chan SW and Blackburn EH. New ways not to make ends meet: telomerase, DNA damage proteins and heterochro-matin. Oncogene 21: 553-563, 2002.
35. Chang E and Harley CB. Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci USA 92: 11190-11194, 1995.
36. Chen T, Tsujimoto N, and Li E. The PWWP domain of Dnmt3a and Dnmt3b is required for directing DNA methylation to the major satellite repeats at pericentric heterochromatin. Mol Cell Biol 24: 9048-9058, 2004.
37. Cheng HL, Mostoslavsky R, Saito S, Manis JP, Gu Y, Patel P, Bronson R, Appella E, Alt FW, and Chua KF. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci USA 100: 10794-10799, 2003.
38. Choi EK, Uyeno S, Nishida N, Okumoto T, Fujimura S, Aoki Y, Nata M, Sagisaka K, Fukuda Y, Nakao K, Yoshi-moto T, Kim YS, and Ono T. Alterations of c-fos gene methylation in the processes of aging and tumorigenesis in human liver. Mutat Res 354: 123-128, 1996.
39. Clayton AL, Hazzalin CA, and Mahadevan LC. Enhanced histone acetylation and transcription: a dynamic perspective. Mol Cell 23: 289-296, 2006.
40. Collado M and Serrano M. The power and the promise of oncogene-induced senescence markers. Nat Rev Cancer 6: 472-476, 2006.
41. Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 24: 519-550, 2001.
42. Corona DF and Tamkun JW. Multiple roles for ISWI in transcription, chromosome organization and DNA replication. Biochim Biophys Acta 1677: 113-119, 2004.
43. Coustou V, Deleu C, Saupe S, and Begueret J. The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog. Proc Natl Acad Sci USA 94: 9773-9778, 1997.
44. Dang W, Steffen KK, Perry R, Dorsey JA, Johnson FB, Shilatifard A, Kaeberlein M, Kennedy BK, and Berger SL. Histone H4 lysine 16 acetylation regulates cellular lifespan. Nature 459: 802-807, 2009.
45. da Silva AM, Payao SL, Borsatto B, Bertolucci PH, and Smith MA. Quantitative evaluation of the rRNA in Alzheimer's disease. Mech Ageing Dev 120: 57-64, 2000.
46. Dario LS, Rosa MA, Mariela E, Roberto G, and Caterina C. Chromatin remodeling agents for cancer therapy. Rev Recent Clin Trials 3: 192-203, 2008.
47. Davis CD, Uthus EO, and Finley JW. Dietary selenium and arsenic affect DNA methylation in vitro in Caco-2 cells and in vivo in rat liver and colon. J Nutr 130: 2903-2909, 2000.
48. Day JK, Bauer AM, DesBordes C, Zhuang Y, Kim BE, Newton LG, Nehra V, Forsee KM, MacDonald RS, Besch-Williford C, Huang TH, and Lubahn DB. Genistein alters methylation patterns in mice. J Nutr 132: 2419S-2423S, 2002.
49. De Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 19: 2100-2110, 2005.
50. Denu JM. Linking chromatin function with metabolic networks: Sir2 family of NAD(\+)-dependent deacetylases. Trends Biochem Sci 28: 41-48, 2003.
51. Druesne N, Pagniez A, Mayeur C, Thomas M, Cherbuy C, Duee PH, Martel P, and Chaumontet C. Diallyl disulfide (DADS) increases histone acetylation and p21(waf1=cip1) expression in human colon tumor cell lines. Carcinogenesis 25: 1227-1236, 2004.
52. Dryden SC, Nahhas FA, Nowak JE, Goustin AS, and Tainsky MA. Role for human SIRT2 NAD-dependent dea-cetylase activity in control of mitotic exit in the cell cycle. Mol Cell Biol 23: 3173-3185, 2003.
53. Eaglestone SS, Cox BS, and Tuite MF. Translation termination efficiency can be regulated in Saccharomyces cerevisiae by environmental stress through a prion-mediated mechanism. EMBO J 18: 1974-1981, 1999.
54. Ebert A, Schotta G, Lein S, Kubicek S, Krauss V, Jenuwein T, and Reuter G. Su(var) genes regulate the balance between euchromatin and heterochromatin in Drosophila. Genes Dev 18: 2973-2983, 2004.
55. Eden S, Hashimshony T, Keshet I, Cedar H, and Thorne AW. DNA methylation models histone acetylation. Nature 394: 842, 1998.
56. Eisen JA, Sweder KS, and Hanawalt PC. Evolution of the SNF2 family of proteins: subfamilies with distinct sequences and functions. Nucleic Acids Res 23: 2715-2723, 1995.
57. Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 21: 5427-5440, 2002.
58. Feil R. Environmental and nutritional effects on the epige-netic regulation of genes. Mutat Res 600: 46-57, 2006.
59. Finkel T, Serrano M, and Blasco MA. The common biology of cancer and ageing. Nature 448: 767-774, 2007.
60. Fischle W, Wang Y, and Allis CD. Histone and chromatin cross-talk. Curr Opin Cell Biol 15: 172-183, 2003.
61. Flanagan JM, Popendikyte V, Pozdniakovaite N, Sobolev M, Assadzadeh A, Schumacher A, Zangeneh M, Lau L, Virtanen C, Wang SC, and Petronis A. Intra-and interin-dividual epigenetic variation in human germ cells. Am J Hum Genet 79: 67-84, 2006.
62. Fraga MF, Agrelo R, and Esteller M. Cross-talk between aging and cancer: the epigenetic language. Ann N Y Acad Sci 1100: 60-74, 2007.
63. Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, Ballestar ML, Heine-Suner D, Cigudosa JC, Urioste M, Benitez J, Boix-Chornet M, Sanchez-Aguilera A, Ling C, Carlsson E, Poulsen P, Vaag A, Stephan Z, Spector TD, Wu YZ, Plass C, and Esteller M. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA 102: 10604-10609, 2005.
64. Fraga MF and Esteller M. Epigenetics and aging: the targets and the marks. Trends Genet 23: 413-418, 2007.
65. Fulco M, Schiltz RL, Iezzi S, King MT, Zhao P, Kashiwaya Y, Hoffman E, Veech RL, and Sartorelli V. Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state. Mol Cell 12: 51-62, 2003.
66. Garcia-Cao M, Gonzalo S, Dean D, and Blasco MA. A role for the Rb family of proteins in controlling telomere length. Nat Genet 32: 415-419, 2002.
67. Garcia-Cao M, O'Sullivan R, Peters AH, Jenuwein T, and Blasco MA. Epigenetic regulation of telomere length in mammalian cells by the Suv39h1 and Suv39h2 histone methyltransferases. Nat Genet 36: 94-99, 2004.
68. Gartner K. A third component causing random variability beside environment and genotype. A reason for the limited success of a 30 year long effort to standardize laboratory animals? Lab Anim 24: 71-77, 1990.
69. Gil J, Bernard D, Martinez D, and Beach D. Polycomb CBX7 has a unifying role in cellular lifespan. Nat Cell Biol. 6: 67-72. Epub 2003 Nov 30.
70. Write to the Help Desk NCBI | NLM | NIH Department of Health & Human Services Privacy Statement | Freedom of Information Act | Disclaimer Aug 7 2006 07:06:54, 2004.
71. Gil J and Peters G. Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol 7: 667-677, 2006.
72. Goh AX, Li C, Sy MS, and Wong BS. Altered prion protein glycosylation in the aging mouse brain. J Neurochem 100: 841-854, 2007.
73. Goldberg AD, Allis CD, and Bernstein E. Epigenetics: a landscape takes shape. Cell 128: 635-638, 2007.
74. Goll MG and Bestor TH. Eukaryotic cytosine methyl-transferases. Annu Rev Biochem 74: 481-514, 2005.
75. Gonzalo S, Garcia-Cao M, Fraga MF, Schotta G, Peters AH, Cotter SE, Eguia R, Dean DC, Esteller M, Jenuwein T, and Blasco MA. Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin. Nat Cell Biol 7: 420-428, 2005.
76. Gonzalo S, Jaco I, Fraga MF, Chen T, Li E, Esteller M, and Blasco MA. DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat Cell Biol 8: 416-424, 2006.
77. Goodarzi AA, Noon AT, Deckbar D, Ziv Y, Shiloh Y, Lo-brich M, and Jeggo PA. ATM signaling facilitates repair of DNA double-strand breaks associated with heterochroma-tin. Mol Cell 31: 167-177, 2008.
78. Gopalakrishnan S, Van Emburgh BO, and Robertson KD. DNA methylation in development and human disease. Mutat Res 647: 30-38, 2008.
79. Gotta M, Strahl-Bolsinger S, Renauld H, Laroche T, Kennedy BK, Grunstein M, and Gasser SM. Localization of Sir2p: the nucleolus as a compartment for silent information regulators. EMBO J 16: 3243-3255, 1997.
80. Green EM, Antczak AJ, Bailey AO, Franco AA, Wu KJ, Yates JR, 3rd, and Kaufman PD. Replication-independent histone deposition by the HIR complex and Asf1. Curr Biol 15: 2044-2049, 2005.
81. Grewal SI and Jia S. Heterochromatin revisited. Nat Rev Genet 8: 35-46, 2007.
82. Groth A, Rocha W, Verreault A, and Almouzni G. Chro-matin challenges during DNA replication and repair. Cell 128: 721-733, 2007.
83. Grummt I. Different epigenetic layers engage in complex crosstalk to define the epigenetic state of mammalian rRNA genes. Hum Mol Genet 16 Spec No 1: R21-R27, 2007.
84. Guenther MG, Levine SS, Boyer LA, Jaenisch R, and Young RA. A chromatin landmark and transcription initiation at most promoters in human cells. Cell 130: 77-88, 2007.
85. Haigis MC and Guarente LP. Mammalian sirtuinSEmerging roles in physiology, aging, and calorie restriction. Genes Dev 20: 2913-2921, 2006.
86. Haines TR, Rodenhiser DI, and Ainsworth PJ. Allele-spe-cific non-CpG methylation of the Nf1 gene during early mouse development. Dev Biol 240: 585-598, 2001.
87. Hark AT, Schoenherr CJ, Katz DJ, Ingram RS, Levorse JM, and Tilghman SM. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19=Igf2 locus. Nature 405: 486-489, 2000.
88. Harley CB, Futcher AB, and Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 345: 458-460, 1990.
89. Harris DA. Cellular biology of prion diseases. Clin Microbiol Rev 12: 429-444, 1999.
90. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 37: 614-636, 1965.
91. He J, Kallin EM, Tsukada Y, and Zhang Y. The H3K36 demethylase Jhdm1b=Kdm2b regulates cell proliferation and senescence through p15(Ink4b). Nat Struct Mol Biol 15: 1169-1175, 2008.
92. Heard E. Delving into the diversity of facultative heterochromatin: the epigenetics of the inactive X chromosome. Curr Opin Genet Dev 15: 482-489, 2005.
93. Hemann MT, Strong MA, Hao LY, and Greider CW. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 107: 67-77, 2001.
94. Herbig U, Ferreira M, Condel L, Carey D, and Sedivy JM. Cellular senescence in aging primates. Science 311: 1257, 2006.
95. Herbig U, Jobling WA, Chen BP, Chen DJ, and Sedivy JM. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol Cell 14: 501-513, 2004.
96. Herbig U and Sedivy JM. Regulation of growth arrest in senescence: telomere damage is not the end of the story. Mech Ageing Dev 127: 16-24, 2006.
97. Herskind AM, McGue M, Holm NV, Sorensen TI, Harvald B, and Vaupel JW. The heritability of human longevity: a population-based study of 2872 Danish twin pairs born 1870-1900. Hum Genet 97: 319-323, 1996.
98. Huang J and Moazed D. Association of the RENT complex with nontranscribed and coding regions of rDNA and a regional requirement for the replication fork block protein Fob1 in rDNA silencing. Genes Dev 17: 2162-2176, 2003.
99. Inayoshi Y, Miyake K, Machida Y, Kaneoka H, Terajima M, Dohda T, Takahashi M, and Iijima S. Mammalian chro-matin remodeling complex SWI=SNF is essential for enhanced expression of the albumin gene during liver development. J Biochem 139: 177-188, 2006.
100. Inoue T, Hiratsuka M, Osaki M, and Oshimura M. The molecular biology of mammalian SIRT proteins: SIRT2 in cell cycle regulation. Cell Cycle 6: 1011-1018, 2007.
101. Issa JP. Epigenetic variation and human disease. J Nutr 132: 2388S-2392S, 2002.
102. Issa JP, Ahuja N, Toyota M, Bronner MP, and Brentnall TA. Accelerated age-related CpG island methylation in ulcera-tive colitis. Cancer Res 61: 3573-3577, 2001.
103. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, and Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 7: 536-540, 1994.
104. Issa JP, Vertino PM, Boehm CD, Newsham IF, and Baylin SB. Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis. Proc Natl Acad Sci USA 93: 11757-11762, 1996.
105. Itahana K, Zou Y, Itahana Y, Martinez JL, Beausejour C, Jacobs JJ, Van Lohuizen M, Band V, Campisi J, and Dimri GP. Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1. Mol Cell Biol. 23: 389-401.
106. Write to the Help Desk NCBI | NLM | NIH Department of Health & Human Services Privacy Statement | Freedom of Information Act | Disclaimer Aug 7 2006 07:06:54, 2003.
107. Jackson-Grusby L, Beard C, Possemato R, Tudor M, Fam-brough D, Csankovszki G, Dausman J, Lee P, Wilson C, Lander E, and Jaenisch R. Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nat Genet 27: 31-39, 2001.
108. Jackson GS and Collinge J. The molecular pathology of CJD: old and new variants. Mol Pathol 54: 393-399, 2001.
109. Jacob RA, Gretz DM, Taylor PC, James SJ, Pogribny IP, Miller BJ, Henning SM, and Swendseid ME. Moderate fo-late depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women. J Nutr 128: 1204-1212, 1998.
110. Jacobs JJ, Kieboom K, Marino S, DePinho RA, and van Lohuizen M. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397: 164-168, 1999.
111. Janzen V, Forkert R, Fleming HE, Saito Y, Waring MT, Dombkowski DM, Cheng T, DePinho RA, Sharpless NE, and Scadden DT. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature 443: 421-426, 2006.
112. Jeyapalan JC, Ferreira M, Sedivy JM, and Herbig U. Accumulation of senescent cells in mitotic tissue of aging primates. Mech Ageing Dev 128: 36-44, 2007.
113. Kaern M, Elston TC, Blake WJ, and Collins JJ. Stochasticity in gene expression: from theories to phenotypes. Nat Rev Genet 6: 451-464, 2005.
114. Kahn A and Fraga MF. Epigenetics and aging: status, challenges, and needs for the future. J Gerontol A Biol Sci Med Sci 64: 195-198, 2009.
115. Kang HL, Benzer S, and Min KT. Life extension in Droso-phila by feeding a drug. Proc Natl Acad Sci USA 99: 838-843, 2002.
116. Kennedy BK, Austriaco NR, Jr., Zhang J, and Guarente L. Mutation in the silencing gene SIR4 can delay aging in S. cerevisiae. Cell 80: 485-496, 1995.
117. Kennedy BK, Gotta M, Sinclair DA, Mills K, McNabb DS, Murthy M, Pak SM, Laroche T, Gasser SM, and Guarente L. Redistribution of silencing proteins from telomeres to the nucleolus is associated with extension of life span in S. cerevisiae. Cell 89: 381-391, 1997.
118. Kia SK, Gorski MM, Giannakopoulos S, and Verrijzer CP. SWI=SNF mediates polycomb eviction and epigenetic re-programming of the INK4b-ARF-INK4a locus. Mol Cell Biol 28: 3457-3464, 2008.
119. Kim J, Inoue K, Ishii J, Vanti WB, Voronov SV, Murchison E, Hannon G, and Abeliovich A. A microRNA feedback circuit in midbrain dopamine neurons. Science 317: 1220-1224, 2007.
120. Kingston RE and Narlikar GJ. ATP-dependent remodeling and acetylation as regulators of chromatin fluidity. Genes Dev 13: 2339-2352, 1999.
121. Kirkwood TB. Understanding the odd science of aging. Cell 120: 437-447, 2005.
122. Koering CE, Pollice A, Zibella MP, Bauwens S, Puisieux A, Brunori M, Brun C, Martins L, Sabatier L, Pulitzer JF, and Gilson E. Human telomeric position effect is determined by chromosomal context and telomeric chromatin integrity. EMBO Rep 3: 1055-1061, 2002.
123. Kouzarides T. Chromatin modifications and their function. Cell 128: 693-705, 2007.
124. Kouzarides T. Histone methylation in transcriptional control. Curr Opin Genet Dev 12: 198-209, 2002.
125. Kretzschmar HA, Prusiner SB, Stowring LE, and DeAr-mond SJ. Scrapie prion proteins are synthesized in neurons. Am J Pathol 122: 1-5, 1986.
126. Krishnamurthy J, Torrice C, Ramsey MR, Kovalev GI, Al-Regaiey K, Su L, and Sharpless NE. Ink4a=Arf expression is a biomarker of aging. J Clin Invest. 114: 1299-1307.
127. Kudlow BA, Kennedy BK, and Monnat RJ, Jr. Werner and Hutchinson-Gilford progeria syndromes: mechanistic basis of human progeroid diseases. Nat Rev Mol Cell Biol 8: 394-404, 2007.
128. Kuningas M, Mooijaart SP, van Heemst D, Zwaan BJ, Slagboom PE, and Westendorp RG. Genes encoding longevity: from model organisms to humans. Aging Cell 7: 270-280, 2008.
129. Kurdistani SK and Grunstein M. Histone acetylation and deacetylation in yeast. Nat Rev Mol Cell Biol 4: 276-284, 2003.
130. Lachner M and Jenuwein T. The many faces of histone ly-sine methylation. Curr Opin Cell Biol 14: 286-298, 2002.
131. Lavu S, Boss O, Elliott PJ, and Lambert PD. Sirtuins-novel therapeutic targets to treat age-associated diseases. Nat Rev Drug Discov 7: 841-853, 2008.
132. Lehnertz B, Ueda Y, Derijck AA, Braunschweig U, Perez-Burgos L, Kubicek S, Chen T, Li E, Jenuwein T, and Peters AH. Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at peri-centric heterochromatin. Curr Biol 13: 1192-1200, 2003.
133. Li E, Bestor TH, and Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69: 915-926, 1992.
134. Li Q, Xiao H, and Isobe K. Histone acetyltransferase activities of cAMP-regulated enhancer-binding protein and p300 in tissues of fetal, young, and old mice. J Gerontol A Biol Sci Med Sci 57: B93-B98, 2002.
135. Lindquist S, Krobitsch S, Li L, and Sondheimer N. Investigating protein conformation-based inheritance and disease in yeast. Philos Trans R Soc Lond B Biol Sci 356: 169-176, 2001.
136. Liu D, O'Connor MS, Qin J, and Songyang Z. Telosome, a mammalian telomere-associated complex formed by multiple telomeric proteins. J Biol Chem 279: 51338-51342, 2004.
137. Lomvardas S, Barnea G, Pisapia DJ, Mendelsohn M, Kirk-land J, and Axel R. Interchromosomal interactions and olfactory receptor choice. Cell 126: 403-413, 2006.
138. Longo VD and Kennedy BK. Sirtuins in aging and age-related disease. Cell 126: 257-268, 2006.
139. Luger K, Mader AW, Richmond RK, Sargent DF, and Richmond TJ. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389: 251-260, 1997.
140. Margueron R, Trojer P, and Reinberg D. The key to development: interpreting the histone code? Curr Opin Genet Dev 15: 163-176, 2005.
141. Mathers JC. Nutritional modulation of ageing: genomic and epigenetic approaches. Mech Ageing Dev 127: 584-589, 2006.
142. Mathers JC, Kennard J, and James OF. Gastrointestinal responses to oats consumption in young adult and elderly rats: digestion, large bowel fermentation and crypt cell proliferation rates. Br J Nutr 70: 567-584, 1993.
143. Matsumoto A. Age-related changes in nuclear receptor coactivator immunoreactivity in motoneurons of the spinal nucleus of the bulbocavernosus of male rats. Brain Res 943: 202-205, 2002.
144. Matthews C, Gorenne I, Scott S, Figg N, Kirkpatrick P, Ritchie A, Goddard M, and Bennett M. Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress. Circ Res 99: 156-164, 2006.
145. Meshorer E, Yellajoshula D, George E, Scambler PJ, Brown DT, and Misteli T. Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells. Dev Cell 10: 105-116, 2006. (Pubitemid 43025681)
146. Michishita E, McCord RA, Berber E, Kioi M, Padilla-Nash H, Damian M, Cheung P, Kusumoto R, Kawahara TL, Barrett JC, Chang HY, Bohr VA, Ried T, Gozani O, and Chua KF. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature 452: 492-496, 2008.
147. Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G, Alvarez P, Brockman W, Kim TK, Koche RP, Lee W, Mendenhall E, O'Donovan A, Presser A, Russ C, Xie X, Meissner A, Wernig M, Jaenisch R, Nusbaum C, Lander ES, and Bernstein BE. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448: 553-560, 2007.
148. Mill J, Dempster E, Caspi A, Williams B, Moffitt T, and Craig I. Evidence for monozygotic twin (MZ) discordance in methylation level at two CpG sites in the promoter region of the catechol-O-methyltransferase (COMT) gene. Am J Med Genet B Neuropsychiatr Genet 141B: 421-425, 2006.
149. Miller D. Ensuring continuity of the paternal genome: potential roles for spermatozoal RNA in mammalian em-bryogenesis. Soc Reprod Fertil Suppl 65: 373-389, 2007.
150. Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, Gagne DJ, Jin L, Boss O, Perni RB, Vu CB, Bemis JE, Xie R, Disch JS, Ng PY, Nunes JJ, Lynch AV, Yang H, Galonek H, Israelian K, Choy W, Iffland A, Lavu S, Medvedik O, Sinclair DA, Olefsky JM, Jirousek MR, Elliott PJ, and Westphal CH. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450: 712-716, 2007.
151. Minamino T and Komuro I. Vascular cell senescence: contribution to atherosclerosis. Circ Res 100: 15-26, 2007.
152. Miska EA, Alvarez-Saavedra E, Townsend M, Yoshii A, Sestan N, Rakic P, Constantine-Paton M, and Horvitz HR. Microarray analysis of microRNA expression in the developing mammalian brain. Genome Biol 5: R68, 2004.
153. Mitchell BD, Hsueh WC, King TM, Pollin TI, Sorkin J, Agarwala R, Schaffer AA, and Shuldiner AR. Heritability of life span in the old order Amish. Am J Med Genet 102: 346-352, 2001.
154. Moser M, Colello RJ, Pott U, and Oesch B. Developmental expression of the prion protein gene in glial cells. Neuron 14: 509-517, 1995.
155. Mostoslavsky R, Chua KF, Lombard DB, Pang WW, Fischer MR, Gellon L, Liu P, Mostoslavsky G, Franco S, Murphy MM, Mills KD, Patel P, Hsu JT, Hong AL, Ford E, Cheng HL, Kennedy C, Nunez N, Bronson R, Frendewey D, Auerbach W, Valenzuela D, Karow M, Hottiger MO, Hursting S, Barrett JC, Guarente L, Mulligan R, Demple B, Yancopoulos GD, and Alt FW. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 124: 315-329, 2006.
156. Motta MC, Divecha N, Lemieux M, Kamel C, Chen D, Gu W, Bultsma Y, McBurney M, and Guarente L. Mammalian SIRT1 represses forkhead transcription factors. Cell 116: 551-563, 2004.
157. Mouillet-Richard S, Ermonval M, Chebassier C, Laplanche JL, Lehmann S, Launay JM, and Kellermann O. Signal transduction through prion protein. Science 289: 1925-1928, 2000.
158. Murayama A, Ohmori K, Fujimura A, Minami H, Yasuzawa-Tanaka K, Kuroda T, Oie S, Daitoku H, Oku-waki M, Nagata K, Fukamizu A, Kimura K, Shimizu T, and Yanagisawa J. Epigenetic control of rDNA loci in response to intracellular energy status. Cell 133: 627-639, 2008.
159. Myant K and Stancheva I. LSH cooperates with DNA methyltransferases to repress transcription. Mol Cell Biol 28: 215-226, 2008.
160. Namy O, Galopier A, Martini C, Matsufuji S, Fabret C, and Rousset JP. Epigenetic control of polyamines by the prion [PSI\+]. Nat Cell Biol 10: 1069-1075, 2008.
161. Narita M, Nunez S, Heard E, Narita M, Lin AW, Hearn SA, Spector DL, Hannon GJ, and Lowe SW. Rb-mediated het-erochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113: 703-716, 2003.
162. Nelson PT, Baldwin DA, Kloosterman WP, Kauppinen S, Plasterk RH, and Mourelatos Z. RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain. RNA 12: 187-191, 2006.
163. Nelson PT and Keller JN. RNA in brain disease: no longer just "the messenger in the middle." J Neuropathol Exp Neurol 66: 461-468, 2007.
164. Nelson PT, Wang WX, and Rajeev BW. MicroRNAs (miR-NAs) in neurodegenerative diseases. Brain Pathol 18: 130-138, 2008.
165. Nemoto S, Fergusson MM, and Finkel T. SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}. J Biol Chem 280: 16456-16460, 2005.
166. Neumeister P, Albanese C, Balent B, Greally J, and Pestell RG. Senescence and epigenetic dysregulation in cancer. Int J Biochem Cell Biol 34: 1475-1490, 2002.
167. Nevins JR. The Rb=E2F pathway and cancer. Hum Mol Genet 10: 699-703, 2001.
168. Ng SS, Yue WW, Oppermann U, and Klose RJ. Dynamic protein methylation in chromatin biology. Cell Mol Life Sci 66: 407-422, 2009.
169. North BJ, Marshall BL, Borra MT, Denu JM, and Verdin E. The human Sir2 ortholog, SIRT2, is an NAD\+-dependent tubulin deacetylase. Mol Cell 11: 437-444, 2003.
170. Oakes CC, Smiraglia DJ, Plass C, Trasler JM, and Robaire B. Aging results in hypermethylation of ribosomal DNA in sperm and liver of male rats. Proc Natl Acad Sci USA 100: 1775-1780, 2003.
171. Oates NA, van Vliet J, Duffy DL, Kroes HY, Martin NG, Boomsma DI, Campbell M, Coulthard MG, Whitelaw E, and Chong S. Increased DNA methylation at the AXIN1 gene in a monozygotic twin from a pair discordant for a caudal duplication anomaly. Am J Hum Genet 79: 155-162, 2006.
172. Oberdoerffer P, Michan S, McVay M, Mostoslavsky R, Vann J, Park SK, Hartlerode A, Stegmuller J, Hafner A, Loerch P, Wright SM, Mills KD, Bonni A, Yankner BA, Scully R, Prolla TA, Alt FW, and Sinclair DA. SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging. Cell 135: 907-918, 2008.
173. Okano M, Bell DW, Haber DA, and Li E. DNA methyl-transferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99:
174. Okano M, Takebayashi S, Okumura K, and Li E. Assignment of cytosine-5 DNA methyltransferases Dnmt3a and Dnmt3b to mouse chromosome bands 12A2-A3 and 2H1 by in situ hybridization. Cytogenet Cell Genet 86: 333-334, 1999.
175. Okano M, Xie S, and Li E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyl-transferases. Nat Genet 19: 219-220, 1998.
176. Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, Mehlhorn I, Huang Z, Fletterick RJ, Cohen FE, et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA 90: 10962-10966, 1993.
177. Peters AH, O'Carroll D, Scherthan H, Mechtler K, Sauer S, Schofer C, Weipoltshammer K, Pagani M, Lachner M, Kohlmaier A, Opravil S, Doyle M, Sibilia M, and Jenuwein T. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 107: 323-337, 2001.
178. Petronis A, Gottesman, II, Kan P, Kennedy JL, Basile VS, Paterson AD, and Popendikyte V. Monozygotic twins exhibit numerous epigenetic differences: clues to twin discordance? Schizophr Bull 29: 169-178, 2003.
179. Pfau R, Tzatsos A, Kampranis SC, Serebrennikova OB, Bear SE, and Tsichlis PN. Members of a family of JmjC domain-containing oncoproteins immortalize embryonic fibroblasts via a JmjC domain-dependent process. Proc Natl Acad Sci USA 105: 1907-1912, 2008.
180. Picard F, Kurtev M, Chung N, Topark-Ngarm A, Sena-wong T, Machado De Oliveira R, Leid M, McBurney MW, and Guarente L. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429: 771-776, 2004.
181. Poulsen P, Esteller M, Vaag A, and Fraga MF. The epige-netic basis of twin discordance in age-related diseases. Pe-diatr Res 61: 38R-42R, 2007.
182. Price JS, Waters JG, Darrah C, Pennington C, Edwards DR, Donell ST, and Clark IM. The role of chondrocyte senescence in osteoarthritis. Aging Cell 1: 57-65, 2002.
183. Prusiner SB. Prions. Proc Natl Acad Sci USA 95: 13363-13383, 1998.
184. Rajewsky N. microRNA target predictions in animals. Nat Genet 38 Suppl: S8-S13, 2006.
185. Ramsahoye BH, Biniszkiewicz D, Lyko F, Clark V, Bird AP, and Jaenisch R. Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. Proc Natl Acad Sci USA 97: 5237-5242, 2000.
186. Rassoulzadegan M, Grandjean V, Gounon P, Vincent S, Gillot I, and Cuzin F. RNA-mediated non-mendelian inheritance of an epigenetic change in the mouse. Nature 441: 469-474, 2006.
187. Ringrose L, Ehret H, and Paro R. Distinct contributions of histone H3 lysine 9 and 27 methylation to locus-specific stability of polycomb complexes. Mol Cell 16: 641-653, 2004.
188. Ringrose L and Paro R. Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins. Annu Rev Genet 38: 413-443, 2004.
189. Rouhi A, Mager DL, Humphries RK, and Kuchenbauer F. MiRNAs, epigenetics, and cancer. Mamm Genome 19: 517-525, 2008.
190. Ruthenburg AJ, Li H, Patel DJ, and Allis CD. Multivalent engagement of chromatin modifications by linked binding modules. Nat Rev Mol Cell Biol 8: 983-994, 2007.
191. Saetrom P, Snove O, Jr., and Rossi JJ. Epigenetics and mi-croRNAs. Pediatr Res 61: 17R-23R, 2007.
192. Sarg B, Koutzamani E, Helliger W, Rundquist I, and Lindner HH. Postsynthetic trimethylation of histone H4 at lysine 20 in mammalian tissues is associated with aging. J Biol Chem 277: 39195-39201, 2002.
193. Sasaki T, Maier B, Bartke A, and Scrable H. Progressive loss of SIRT1 with cell cycle withdrawal. Aging Cell 5: 413-422, 2006.
194. Scaffidi P and Misteli T. Lamin A-dependent nuclear defects in human aging. Science 312: 1059-1063, 2006.
195. Schotta G, Lachner M, Sarma K, Ebert A, Sengupta R, Reuter G, Reinberg D, and Jenuwein T. A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin. Genes Dev 18: 1251-1262, 2004.
196. Sengupta N and Seto E. Regulation of histone deacetylase activities. J Cell Biochem 93: 57-67, 2004.
197. Serrano M, Lin AW, McCurrach ME, Beach D, and Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88: 593-602, 1997.
198. Shanahan F, Seghezzi W, Parry D, Mahony D, and Lees E. Cyclin E associates with BAF155 and BRG1, components of the mammalian SWI-SNF complex, and alters the ability of BRG1 to induce growth arrest. Mol Cell Biol 19: 1460-1469, 1999.
199. Shumaker DK, Dechat T, Kohlmaier A, Adam SA, Bo-zovsky MR, Erdos MR, Eriksson M, Goldman AE, Khuon S, Collins FS, Jenuwein T, and Goldman RD. Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature aging. Proc Natl Acad Sci USA 103: 8703-8708, 2006.
200. Sinclair DA. Toward a unified theory of caloric restriction and longevity regulation. Mech Ageing Dev 126: 987-1002, 2005.
201. Singhal RP, Mays-Hoopes LL, and Eichhorn GL. DNA methylation in aging of mice. Mech Ageing Dev 41: 199-210, 1987.
202. Smith BC, Hallows WC, and Denu JM. Mechanisms and molecular probes of sirtuins. Chem Biol 15: 1002-1013, 2008.
203. Smith CL and Peterson CL. ATP-dependent chromatin remodeling. Curr Top Dev Biol 65: 115-148, 2005.
204. So K, Tamura G, Honda T, Homma N, Waki T, Togawa N, Nishizuka S, and Motoyama T. Multiple tumor suppressor genes are increasingly methylated with age in non-neoplastic gastric epithelia. Cancer Sci 97: 1155-1158, 2006.
205. Sommer M, Poliak N, Upadhyay S, Ratovitski E, Nelkin BD, Donehower LA, and Sidransky D. DeltaNp63alpha overexpression induces downregulation of Sirt1 and an accelerated aging phenotype in the mouse. Cell Cycle 5: 2005-2011, 2006.
206. Sterner DE and Berger SL. Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev 64: 435-459, 2000.
207. Takatsu M, Uyeno S, Komura J, Watanabe M, and Ono T. Age-dependent alterations in mRNA level and promoter methylation of collagen alpha1(I) gene in human peri-odontal ligament. Mech Ageing Dev 110: 37-48, 1999.
208. Taylor DM, Maxwell MM, Luthi-Carter R, and Kazantsev AG. Biological and potential therapeutic roles of sirtuin deacetylases. Cell Mol Life Sci 65: 4000-4018, 2008.
209. Tham WH and Zakian VA. Transcriptional silencing at Saccharomyces telomeres: implications for other organisms. Oncogene 21: 512-521, 2002.
210. Tommerup H, Dousmanis A, and de Lange T. Unusual chromatin in human telomeres. Mol Cell Biol 14: 5777-5785, 1994.
211. True HL. The battle of the fold: chaperones take on prions. Trends Genet 22: 110-117, 2006.
212. True HL and Lindquist SL. A yeast prion provides a mechanism for genetic variation and phenotypic diversity. Nature 407: 477-483, 2000.
213. Tse C, Sera T, Wolffe AP, and Hansen JC. Disruption of higher-order folding by core histone acetylation dramatically enhances transcription of nucleosomal arrays by RNA polymerase III. Mol Cell Biol 18: 4629-4638, 1998.
214. Vaquero A, Loyola A, and Reinberg D. The constantly changing face of chromatin. Sci Aging Knowledge Environ 2003: RE4, 2003.
215. Vaquero A, Scher M, Erdjument-Bromage H, Tempst P, Serrano L, and Reinberg D. SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation. Nature 450: 440-444, 2007.
216. Vaquero A, Scher M, Lee D, Erdjument-Bromage H, Tempst P, and Reinberg D. Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin. Mol Cell 16: 93-105, 2004.
217. Vaquero A, Scher MB, Lee DH, Sutton A, Cheng HL, Alt FW, Serrano L, Sternglanz R, and Reinberg D. SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis. Genes Dev 20: 1256-1261, 2006.
218. Vaquero A, Sternglanz R, and Reinberg D. NAD\+-dependent deacetylation of H4 lysine 16 by class III HDACs. Oncogene 26: 5505-5520, 2007.
219. Varga-Weisz P. ATP-dependent chromatin remodeling factors: nucleosome shufflers with many missions. Oncogene 20: 3076-3085, 2001.
220. Vasile E, Tomita Y, Brown LF, Kocher O, and Dvorak HF. Differential expression of thymosin beta-10 by early passage and senescent vascular endothelium is modulated by VPF=VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis. FASEB J 15: 458-466, 2001.
221. Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pan-dita TK, Guarente L, and Weinberg RA. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107: 149-159, 2001.
222. Vignali M, Hassan AH, Neely KE, and Workman JL. ATP-dependent chromatin-remodeling complexes. Mol Cell Biol 20: 1899-1910, 2000.
223. Vo N and Goodman RH. CREB-binding protein and p300 in transcriptional regulation. J Biol Chem 276: 13505-13508, 2001.
224. Voigtlander T, Kloppel S, Birner P, Jarius C, Flicker H, Verghese-Nikolakaki S, Sklaviadis T, Guentchev M, and Budka H. Marked increase of neuronal prion protein immunoreactivity in Alzheimer's disease and human prion diseases. Acta Neuropathol 101: 417-423, 2001.
225. Waki T, Tamura G, Sato M, and Motoyama T. Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samples. Oncogene 22: 4128-4133, 2003.
226. Wang F, Nguyen M, Qin FX, and Tong Q. SIRT2 deacety-lates FOXO3a in response to oxidative stress and caloric restriction. Aging Cell 6: 505-514, 2007.
227. Wang GG, Allis CD, and Chi P. Chromatin remodeling and cancer, Part I: covalent histone modifications. Trends Mol Med 13: 363-372, 2007.
228. Wang GG, Allis CD, and Chi P. Chromatin remodeling and cancer, Part II: ATP-dependent chromatin remodeling. Trends Mol Med 13: 373-380, 2007. (Pubitemid 47385382)
229. Wang WX, Rajeev BW, Stromberg AJ, Ren N, Tang G, Huang Q, Rigoutsos I, and Nelson PT. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci 28: 1213-1223, 2008.
230. Wang Y, Liang Y, and Lu Q. MicroRNA epigenetic alterations: predicting biomarkers and therapeutic targets in human diseases. Clin Genet 74: 307-315, 2008.
231. Wei W, Hemmer RM, and Sedivy JM. Role of p14(ARF) in replicative and induced senescence of human fibroblasts. Mol Cell Biol 21: 6748-6757, 2001.
232. Wickner RB. [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 264: 566-569, 1994.
233. Wiemann SU, Satyanarayana A, Tsahuridu M, Tillmann HL, Zender L, Klempnauer J, Flemming P, Franco S, Blasco MA, Manns MP, and Rudolph KL. Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis. FASEB J 16: 935-942, 2002.
234. Williams EA, Coxhead JM, and Mathers JC. Anti-cancer effects of butyrate: use of micro-array technology to investigate mechanisms. Proc Nutr Soc 62: 107-115, 2003.
235. Williams WM, Stadtman ER, and Moskovitz J. Ageing and exposure to oxidative stress in vivo differentially affect cellular levels of PrP in mouse cerebral microvessels and brain parenchyma. Neuropathol Appl Neurobiol 30: 161-168, 2004.
236. Wilson VL and Jones PA. DNA methylation decreases in aging but not in immortal cells. Science 220: 1055-1057, 1983.
237. Wilson VL, Smith RA, Ma S, and Cutler RG. Genomic 5-methyldeoxycytidine decreases with age. J Biol Chem 262: 9948-9951, 1987.
238. Wong AH, Gottesman, II, and Petronis A. Phenotypic differences in genetically identical organisms: the epigenetic perspective. Hum Mol Genet 14 Spec No 1: R11-R18, 2005.
239. Xi S, Zhu H, Xu H, Schmidtmann A, Geiman TM, and Muegge K. Lsh controls Hox gene silencing during development. Proc Natl Acad Sci USA 104: 14366-14371, 2007.
240. Yatabe Y, Tavare S, and Shibata D. Investigating stem cells in human colon by using methylation patterns. Proc Natl Acad Sci USA 98: 10839-10844, 2001.
241. Ying SY, Chang DC, and Lin SL. The microRNA (miRNA): overview of the RNA genes that modulate gene function. Mol Biotechnol 38: 257-268, 2008.
242. Zhang R and Adams PD. Heterochromatin and its relationship to cell senescence and cancer therapy. Cell Cycle 6: 784-789, 2007.
243. Zhang R, Chen W, and Adams PD. Molecular dissection of formation of senescence-associated heterochromatin foci. Mol Cell Biol 27: 2343-2358, 2007.
244. Zhang R, Poustovoitov MV, Ye X, Santos HA, Chen W, Daganzo SM, Erzberger JP, Serebriiskii IG, Canutescu AA, Dunbrack RL, Pehrson JR, Berger JM, Kaufman PD, and Adams PD. Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Dev Cell 8: 19-30, 2005.
245. Zhou YB, Gerchman SE, Ramakrishnan V, Travers A, and Muyldermans S. Position and orientation of the globular domain of linker histone H5 on the nucleosome. Nature 395: 402-405, 1998.
246. Zhu H, Geiman TM, Xi S, Jiang Q, Schmidtmann A, Chen T, Li E, and Muegge K. Lsh is involved in de novo meth-ylation of DNA. EMBO J 25: 335-345, 2006.